West Pharmaceutical Services, Inc. Stock
Stocks
WST
US9553061055
Medical Equipment, Supplies & Distribution
|
Market Closed -
NYSE
04:03:50 2026-09-28 pm EDT
|
5-day change | 1st Jan Change | ||
| 375.65 USD | +1.41% |
|
+3.83% | +36.53% |
| Sep. 23 | US companies face rise in cyber attacks | RE |
| Sep. 22 | West Pharmaceutical Poised to See EPS Upside to Current 2027 Wall Street Estimates, Morgan Stanley Says | MT |
| Market Cap | 26.44B 23.25B 21.99B 19.94B 37.45B 2,538B 37.67B 263B 102B 1,295B 99.25B 97.1B 4,161B | P/E 2026 * |
43.8x | P/E 2027 * | 38.1x |
|---|---|---|---|---|---|
| Enterprise Value | 25.93B 22.81B 21.57B 19.56B 36.74B 2,489B 36.95B 258B 99.73B 1,270B 97.36B 95.26B 4,082B | EV / Sales 2026 * |
7.69x | EV / Sales 2027 * | 7.1x |
| Free-Float |
92.88% | Yield 2026 * |
0.24% | Yield 2027 * | 0.26% |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| WST | Delayed | |
CBOE
| WST | Real-time | |
|
London S.E.
| 0ADY | Delayed | |
|
Deutsche Boerse AG
| WPS | Delayed | |
|
Tradegate
| WPS | Real-time | |
|
Börse Stuttgart
| WPS | Delayed | |
|
Boerse Muenchen
| WPS | Real-time | |
|
Berne S.E.
| WPS | End-of-day quote | |
|
Borsa Italiana
| 1WST | End-of-day quote |
Last Transcript: West Pharmaceutical Services, Inc.
| Aug. 26 | West to Participate in Upcoming Investor Conferences | PR |
| Jul. 23 | West Pharmaceutical: Q2 Earnings Snapshot | AQ |
| Jul. 23 | West Reports Second-Quarter 2026 Results | PR |
| Jul. 21 | West Declares Quarterly Dividend | PR |
| Jul. 07 | West to Host Second-Quarter 2026 Conference Call | PR |
| 1 day | +1.41% | ||
| 1 week | +3.83% | ||
| Current month | +10.13% | ||
| 1 month | +11.31% | ||
| 3 months | +7.07% | ||
| 6 months | +54.37% | ||
| Current year | +36.53% |
| 1 week | 366.55 |  | 382.71 |
| 1 month | 331.99 | | 382.71 |
| Current year | 223.83 | | 386 |
| 1 year | 223.83 | | 386 |
| 3 years | 187.43 | | 413.7 |
| 5 years | 187.43 | | 475 |
| 10 years | 70.17 | | 475.35 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michel Lagarde
CEO | Chief Executive Officer | 52 | 2026-08-30 |
Robert McMahon
DFI | Director of Finance/CFO | 57 | 2025-08-03 |
Devesh Mathur
CTO | Chief Tech/Sci/R&D Officer | - | 2025-07-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Mark Buthman
BRD | Director/Board Member | 65 | 2011-01-31 |
Douglas Michels
BRD | Director/Board Member | 69 | 2011-03-06 |
William Feehery
BRD | Director/Board Member | 56 | 2012-02-11 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/15/26 | Exercice | Head of Human Resources | 7,572 | 0.0108% | ||
| 9/8/26 | Free | Chief Executive Officer | 51,798 | 0.0736% | ||
| 9/8/26 | Exercice | Head of Human Resources | 24,405 | 0.0347% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.41% | +3.83% | +43.64% | -0.90% | 26.07B | |
| -0.31% | -1.94% | -24.39% | +2.91% | 175B | |
| +0.97% | -2.45% | -5.01% | +13.74% | 113B | |
| -1.01% | -4.01% | -1.04% | +66.14% | 58.57B | |
| +0.01% | +1.73% | -0.42% | -30.03% | 50.07B | |
| -0.87% | +0.52% | +14.41% | +51.78% | 49.92B | |
| +0.07% | -2.79% | +29.18% | -9.20% | 32.69B | |
| +1.07% | +9.73% | - | - | 30.44B | |
| +1.98% | +7.44% | +26.26% | -1.90% | 23.55B | |
| -0.15% | -0.29% | -6.15% | +14.46% | 21.53B | |
| Average | +0.32% | +1.64% | +8.50% | +11.89% | 58.15B | |
| Weighted average by Cap. | +0.12% | -0.13% | -2.95% | +12.64% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.37B 2.97B 2.81B 2.55B 4.78B 324B 4.81B 33.6B 12.98B 165B 12.67B 12.39B 531B | 3.59B 3.15B 2.98B 2.71B 5.08B 344B 5.11B 35.72B 13.79B 176B 13.47B 13.18B 565B |
| Net income | 617M 543M 513M 466M 875M 59.27B 880M 6.15B 2.37B 30.24B 2.32B 2.27B 97.19B | 703M 618M 584M 530M 995M 67.44B 1B 7B 2.7B 34.41B 2.64B 2.58B 111B |
| Net Debt | -503M -443M -419M -380M -713M -48.31B -717M -5.01B -1.94B -24.65B -1.89B -1.85B -79.22B | -973M -856M -810M -734M -1.38B -93.45B -1.39B -9.69B -3.74B -47.68B -3.65B -3.58B -153B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-28 | $375.65 | +1.41% | 567,550 |
| 26-09-25 | $370.44 | -0.85% | 434,011 |
| 26-09-24 | $373.60 | -0.60% | 715,930 |
| 26-09-23 | $375.87 | +1.29% | 876,987 |
| 26-09-22 | $371.09 | +2.57% | 734,703 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- WST Stock
Select your edition
All financial news and data tailored to specific country editions
